Vaccine

12 March 2021 News release Geneva The World Health Organization (WHO) listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The …

The World Health Organization (WHO) and Chubb Limited (NYSE: CB), through ESIS Inc., a Chubb company, signed an agreement on behalf of the COVAX Facility on 17 February 2021 for …

Declaration We must accelerate vaccine equity for all health workers – now Health and care workers have been at the forefront of the pandemic response: often under protected and over …

AstraZeneca/Oxford-developed vaccines to reach countries in the coming weeks 15 February 2021 The World Health Organization (WHO) listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the …

The Department of Drug Administration (DDA) has decided to approve ‘COVISHIELD’ COVID-19 vaccine for emergency use in Nepal. DDA provided the conditional permission for emergency authorisation of COVISHEILD vaccine against …

New Delhi, 13 January 2021 – On this day in 2011, WHO South-East Asia Region reported its last case of wild poliovirus from West Bengal in India. A decade later, …

WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access. The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine …